Literature DB >> 27657519

Relievers, controllers, and inhaler technique: A physician-patient challenge.

Joseph A Bellanti, Russell A Settipane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27657519      PMCID： PMC5013232          DOI： 10.2500/aap.2016.37.3989

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN： 1088-5412            Impact factor:   2.587


× No keyword cloud information.
  29 in total

1.  Dosing of European sublingual immunotherapy maintenance solutions relative to monthly recommended dosing of subcutaneous immunotherapy.

Authors:  Désirée E Larenas-Linnemann; Ralph Mösges
Journal:  Allergy Asthma Proc       Date:  2016 Jan-Feb       Impact factor: 2.587

2.  Effect of Lactobacillus rhamnosus GG and vitamin D supplementation on the immunologic effectiveness of grass-specific sublingual immunotherapy in children with allergy.

Authors:  Joanna Jerzynska; Wlodzimierz Stelmach; Joanna Balcerak; Katarzyna Woicka-Kolejwa; Blazej Rychlik; Andrzej Blauz; Marcin Wachulec; Piotr Stelmach; Pawel Majak; Iwona Stelmach
Journal:  Allergy Asthma Proc       Date:  2016-07       Impact factor: 2.587

Review 3.  Electronic health records-Applications for the allergist/immunologist: All that glitters is not gold.

Authors:  Lawrence D Frenkel
Journal:  Allergy Asthma Proc       Date:  2016-07       Impact factor: 2.587

Review 4.  Selection of patients for sublingual immunotherapy (SLIT) versus subcutaneous immunotherapy (SCIT).

Authors:  Farnaz Tabatabaian; Thomas B Casale
Journal:  Allergy Asthma Proc       Date:  2015 Mar-Apr       Impact factor: 2.587

Review 5.  Quality of life in patients with urticaria and angioedema: assessing burden of disease.

Authors:  David Weldon
Journal:  Allergy Asthma Proc       Date:  2014 Jan-Feb       Impact factor: 2.587

6.  Safety profile of oral immunotherapy with cow's milk and hen egg: A 10-year experience in controlled trials.

Authors:  Giovanni B Pajno; Lucia Caminiti; Fernanda Chiera; Giuseppe Crisafulli; Giuseppina Salzano; Stefania Arasi; Giovanni Passalacqua
Journal:  Allergy Asthma Proc       Date:  2016-09       Impact factor: 2.587

7.  Health care resource use and associated costs among patients with seasonal versus perennial allergic rhinitis.

Authors:  Kathleen Lang; Felicia Allen-Ramey; Huan Huang; Marvin Rock; Elise Kaufman; Mark S Dykewicz
Journal:  Allergy Asthma Proc       Date:  2016-09       Impact factor: 2.587

8.  The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis.

Authors:  Joanna Jerzynska; Wlodzimierz Stelmach; Blażej Rychlik; Joanna Lechańska; Daniela Podlecka; Iwona Stelmach
Journal:  Allergy Asthma Proc       Date:  2016 Mar-Apr       Impact factor: 2.587

9.  SQ grass sublingual allergy immunotherapy tablet for disease-modifying treatment of grass pollen allergic rhinoconjunctivitis.

Authors:  Ronald Dahl; Graham Roberts; Jacques de Blic; G Walter Canonica; Jörg Kleine-Tebbe; Hendrik Nolte; Simon Lawton; Harold S Nelson
Journal:  Allergy Asthma Proc       Date:  2016-01-21       Impact factor: 2.587

10.  Anxiety but not depression symptoms are associated with greater perceived dyspnea in asthma during bronchoconstriction.

Authors:  Hong Lin Li; Xiao Li He; Bing Miao Liang; Hong Ping Zhang; Yan Wang; Gang Wang
Journal:  Allergy Asthma Proc       Date:  2015 Nov-Dec       Impact factor: 2.587
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.